Evidence map›Paper›PMID 36494343›Full record

ArticleNature communications2022

High-throughput robust single-cell DNA methylation profiling with sciMETv2.

Ruth V Nichols, Brendan L O'Connell, Ryan M Mulqueen, Jerushah Thomas, Ashley R Woodfin, Sonia Acharya, Gail Mandel, Dmitry Pokholok, Frank J Steemers, Andrew C Adey

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Epigenetic networks coordinate DNA methylation across the genome.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Ruth V NicholsDepartment of Molecular & Medical Genetics, Oregon Health & Science University, Portland, OR, USA.ORCID http://orcid.org/0000-0002-8810-1126
Brendan L O'ConnellDepartment of Molecular & Medical Genetics, Oregon Health & Science University, Portland, OR, USA.ORCID http://orcid.org/0000-0001-7757-4561
Ryan M MulqueenCancer Early Detection Advanced Research Institute, Oregon Health & Science University, Portland, OR, USA.ORCID http://orcid.org/0000-0002-3903-7594
Jerushah ThomasScale Biosciences, San Diego, CA, USA.
Ashley R WoodfinScale Biosciences, San Diego, CA, USA.
Sonia AcharyaDepartment of Molecular & Medical Genetics, Oregon Health & Science University, Portland, OR, USA.
Gail MandelVollum Institute for Neuroscience, Oregon Health & Science University, Portland, OR, USA.ORCID http://orcid.org/0000-0003-2085-4516
Dmitry PokholokScale Biosciences, San Diego, CA, USA.
Frank J SteemersScale Biosciences, San Diego, CA, USA.
Andrew C AdeyDepartment of Molecular & Medical Genetics, Oregon Health & Science University, Portland, OR, USA. adey@ohsu.edu.ORCID http://orcid.org/0000-0001-7648-8717
Oregon Health & Science University · US

Funding

Defining the epigentic landscape at single cell resolutionR35GM124704 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI ADEY, ANDREW · 2017 to 2021
$2.3M
High-content single-cell epigenetic technologies scalable to the human brainRF1MH128842 · NIMH · OREGON HEALTH & SCIENCE UNIVERSITY · PI ADEY, ANDREW · 2021 to 2021
$1.9M
NIMH NIH HHS RF1 MH128842U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R35GM124704U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) RF1MH128842
6 · The paper itself

Abstract

DNA methylation is a key epigenetic property that drives gene regulatory programs in development and disease. Current single-cell methods that produce high quality methylomes are expensive and low throughput without the aid of extensive automation. We previously described a proof-of-principle technique that enabled high cell throughput; however, it produced only low-coverage profiles and was a difficult protocol that required custom sequencing primers and recipes and frequently produced libraries with excessive adapter contamination. Here, we describe a greatly improved version that generates high-coverage profiles (~15-fold increase) using a robust protocol that does not require custom sequencing capabilities, includes multiple stopping points, and exhibits minimal adapter contamination. We demonstrate two versions of sciMETv2 on primary human cortex, a high coverage and rapid version, identifying distinct cell types using CH methylation patterns. These datasets are able to be directly integrated with one another as well as with existing snmC-seq2 datasets with little discernible bias. Finally, we demonstrate the ability to determine cell types using CG methylation alone, which is the dominant context for DNA methylation in most cell types other than neurons and the most applicable analysis outside of brain tissue.

Indexed as

DNA MethylationHigh-Throughput Nucleotide SequencingEpigenomicsHumansSequence Analysis, DNASoftware

Identifiers

PMID36494343
PMCPMC9734657
OpenAlexW4311662904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.